Wellington Management Group LLP Crispr Therapeutics Ag Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $41.3 Million - $89.8 Million	-518,146 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $23.4 Million - $30 Million	-298,249 Reduced 36.53%	518,146 $43.3 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $4.14 Million - $8.17 Million	107,443 Added 15.16%	816,395 $60 Million
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $323,866 - $601,288	9,616 Added 1.38%	708,952 $30.1 Million
Q4 2019 Feb 11, 2020	BUY	$36.68 - $73.13 $25.7 Million - $51.1 Million	699,336 New	699,336 $42.6 Million

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.